Burzynski: China antineoplaston publications

http://www.china-burzynski.com
——————————————————————
http://www.china-burzynski.com/lczl/bingrengushi_135135.html
——————————————————————
http://www.china-burzynski.com/lxwm
China Antineoplaston
======================================
(pg. 8 of 22: Human-derived compounds – Antineoplastons and CDA-2)
http://ejournals.library.ualberta.ca/index.php/JPPS/article/download/9147/7453
======================================
1990 – Pharmacokinetic study of radioactive antineoplaston A10 in rats and mice
http://www.ncbi.nlm.nih.gov/pubmed/2092961
Drugs Exp Clin Res 16 (7): 351-5 (1990)
http://www.ncbi.nlm.nih.gov/m/pubmed/2092961
Drugs Exp Clin Research
======================================
1990 – Studies of the released rate and bioavailability of antineoplaston A10 capsule
http://www.ncbi.nlm.nih.gov/pubmed/2092962
Drugs Exp Clin Res 16(7):357-9 (1990)
http://www.ncbi.nlm.nih.gov/m/pubmed/2092962
Shandong Medical University, Department of Pharmacy, Jinan, China
http://www.wikigenes.org/e/chem/e/56260.html
======================================
4/15/2009 – antineoplaston AS2-5 (Part I)
3/6/2009 – ePub
http://www.ncbi.nlm.nih.gov/pubmed/19329328
Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I)
http://www.ncbi.nlm.nih.gov/m/pubmed/19329328
Bioorganic & Medicinal Chemistry
Volume 17, Issue 8, 15 April 2009, Pages 3053–3060
Bioorg Med Chem. 2009 Apr 15;17(8):3053-60. doi: 10.1016/j.bmc.2009.02.063. Epub 2009 Mar 6
======================================
4/15/2009 – antineoplaston AS2-5 (Part II)
http://www.ncbi.nlm.nih.gov/pubmed/19339187
Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II)
http://www.ncbi.nlm.nih.gov/m/pubmed/19339187
Volume 17, Issue 8, 15 April 2009, Pages 3061–3071
http://www.sciencedirect.com/science/article/pii/S0968089609002478
Bioorg Med Chem 17(8):11 (2009)
http://services.elsevier.com/SDWebExport/export/figure/S0968089609002478/1-s2.0-S0968089609002478-gr8.jpg/ppt
Bioorganic & Medicinal Chemistry
Bioorg Med Chem. 2009 Apr 15;17(8):3061-71. doi: 10.1016/j.bmc.2009.03.017. Epub 2009 Mar 14
School of Pharmaceutical Sciences, Shandong University, Shandong Province, PR China
Bioorg Med Chem. 4/2009 15;17(8):3061-71. doi: 10.1016/j.bmc.2009.03.017. Epub 3/14/2009
DOI: 10.1016/j.bmc.2009.03.017
Bioorganic and Medicinal Chemistry, Elsevier
======================================
10/1/2010 – Antineoplaston A10 phenylacetyl glutamine (PG) – (S)-2-((S)-2-(4-(3-[18F]fluoropropyl)benzamido)-3-phenylpropanamido)pentanedioic acid labeled with 18F
http://www.springerlink.com/content/tj0177485773007t
(S)-2-((S)-2-(4-(3-[18 F] fluoropropyl) benzamido)-3-phenylpropanamido) pentanedioic acid labeled with 18 F
http://link.springer.com/article/10.1007%2Fs10967-010-0633-2?LI=true
3-[(phenylacetyl)amino]-2,6-piperidinedione hydrolysis studies with improved synthesis and characterization of hydrolysates
http://www.springerlink.com/content/tj0177485773007t
Journal of Radioanalytical and Nuclear Chemistry, 2010, 286, 1, 135
http://link.springer.com/article/10.1007%2Fs10967-010-0633-2
October 2010, Volume 286, Issue 1, pp 135-140
http://link.springer.com/article/10.1007/s10967-010-0633-2/fulltext.html
DOI
10.1007/s10967-010-0633-2
http://onlinelibrary.wiley.com/doi/10.1021/js960120y/abstract
As degradation product of Antineoplaston A10 in vivo, phenylacetyl glutamine
http://www.springerlink.com/content/tj0177485773007t
Burzynski References: 5. – 6.

Advertisement